Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index.

Novel drug targets for sustained reduction in body mass index (BMI) are needed to curb the epidemic of obesity, which affects 650 million individuals worldwide and is a causal driver of cardiovascular and metabolic disease and mortality. Previous studies reported that the Arg95Ter nonsense variant o...

Full description

Saved in:

Bibliographic Details
Main Authors:	Allan Gurtan, John Dominy, Shareef Khalid, Linh Vong, Shari Caplan, Treeve Currie, Sean Richards, Lindsey Lamarche, Daniel Denning, Diana Shpektor, Anastasia Gurinovich, Asif Rasheed, Shahid Hameed, Subhan Saeed, Imran Saleem, Anjum Jalal, Shahid Abbas, Raffat Sultana, Syed Zahed Rasheed, Fazal-Ur-Rehman Memon, Nabi Shah, Mohammad Ishaq, Amit V Khera, John Danesh, Philippe Frossard, Danish Saleheen
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2022-04-01
Series:	PLoS Genetics
Online Access:	https://journals.plos.org/plosgenetics/article/file?id=10.1371/journal.pgen.1010093&type=printable
Tags:	Add Tag No Tags, Be the first to tag this record!

Be the first to leave a comment!

Analyzing human knockouts to validate GPR151 as a therapeutic target for reduction of body mass index.

Similar Items